AbbVie Inc (ABBV)
79.85
+0.39 +0.49%
NYSE
May 20, 14:58
Delayed 2m
USD
View All Key Stats
ABBV Key Stats
| Income Statement | |
| Revenue (TTM) | 32.65B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 3.485 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 5.36B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 78.36% |
| Profit Margin (Quarterly) | 31.37% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 118.04B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.712 |
| PE Ratio (TTM) | 22.91 |
| Price to Book Value | -- |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 2.91B |
| Return on Equity (TTM) | Upgrade |
View All ABBV News
ABBV News
-
WireHeadlineTime (ET)
-
Yahoo05/20 12:31
-
Yahoo05/20 09:02
-
MT Newswires05/20 08:23
-
SA Breaking News05/20 07:36
-
Yahoo05/19 07:00
-
Yahoo05/17 17:19
-
MT Newswires05/17 10:30
-
Yahoo05/17 09:19
-
SA Breaking News05/17 09:11
-
Yahoo05/17 09:00
View All Events
ABBV Events
| Date | Type | Description |
|---|---|---|
| 07/26/2019 09:00 EDT | Misc | AbbVie Inc Second Quarter Earnings Conference Call in 2019 |
| 07/26/2019 | Earnings | AbbVie Inc Second Quarter Earnings in 2019 Release |
| 04/25/2019 09:00 EDT | Misc | AbbVie Inc First Quarter Earnings Conference Call in 2019 |
| 04/25/2019 | Earnings | AbbVie Inc First Quarter Earnings in 2019 Release |
| 04/12/2019 | Dividends | Amount: 1.07, Declared Date: Feb 21 2019, Pay Date: May 15 2019 |
| 02/27/2019 | Misc | AbbVie Inc Annual Report in 2018 |
| 01/25/2019 08:00 CST | Misc | AbbVie Inc Fourth Quarter Earnings Conference Call in 2018 |
| 01/25/2019 | Earnings | AbbVie Inc Fourth Quarter Earnings in 2018 Release |
| 01/14/2019 | Dividends | Amount: 1.07, Declared Date: Nov 02 2018, Pay Date: Feb 15 2019 |
| 11/02/2018 08:00 CDT | Misc | AbbVie Inc Third Quarter Earnings Conference Call in 2018 |
ABBV Fundamentals
Income Statement View Statement
ABBV Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
ABBV One Page Reports
- One Page Report Download
ABBV Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 79.85 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.abbvieinvestor.com
- Investor Relations URL: http://www.abbvieinvestor.com/phoenix.zhtml?c=251551&p=irol-IRHome
- HQ State/Province: Illinois
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Value
- Next Earnings Release: Jul. 26, 2019
- Last Earnings Release: Apr. 25, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: Apr. 12, 2019
- Description: AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013.
Excel Add-In Codes
- Name: =YCI("ABBV","name")
- Description: =YCI("ABBV","description")
- Sector: =YCI("ABBV","sector")
- Industry: =YCI("ABBV","industry")
- Est. Current Fiscal Year End: =YCI("ABBV","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other ABBV Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- ABBV Tweets Stocktwits
Advertisement
